Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Board memberships
- Rocket Pharmaceuticals, Inc.
- Avidity Biosciences, Inc.
Updated Jul 16, 2026
BOESS CARSTEN has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 22.9K | $0.00 | |
| 2026-02-27 | RNAM | Avidity Biosciences, Inc. | D — Derivative transaction | 6.7K | — | |
| 2025-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 30.0K | $0.00 | |
| 2025-06-10 | RNAM | Avidity Biosciences, Inc. | A — Grant or award | 6.7K | $0.00 |
BOESS CARSTEN is a corporate insider — currently tracked as Insider of ROCKET PHARMACEUTICALS, INC. (RCKT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BOESS CARSTEN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.